Nvidia shares rose on Thursday after the chip giant's revenue guidance reassured investors that AI demand will remain strong.

Nvidia reportedly agreed to buy open source AI platform Hugging Face for $12.9 billion as the chipmaker expands deeper into the AI ecosystem.

The Chinese AI company said it had already launched the model globally in stealth mode for a week.

Nvidia CEO Jensen Huang did it again.

Nvidia CEO Jensen Huang defended the chipmaker’s growing role in financing AI companies, calling its investments a “once in a generation” opportunity.

"Our demand is much greater than 70%," CEO Jensen Huang said on the earnings call.

The growth forecast is likely to reinvigorate narratives around the so-called AI supercycle.

Salesforce CEO Marc Benioff pushed back against “SaaSpocalypse” fears.

These are the stocks posting the largest moves in after-hour trading.

New products accounted for 30% of total bookings and Okta said it closed dozens of AI deals during the period

CrowdStrike shares have surged 61% this year to new highs as the threat from frontier AI has fueled demand for advanced security tools.

Salesforce's Anthropic stake led to higher profit in the latest quarter.

"We're delivering a dynamic interface that thinks, reasons, and acts," Salesforce CEO Marc Benioff said in a statement.

The 37-page report walks through the actions that OpenAI's models took during a series of evaluations prior to and during the Hugging Face breach.

Anthropic will rent around 460 megawatts of compute capacity at an Nscale data center development in West Virgina, according to sources.

"Somehow the narrative has turned to say that it was not good for Meta. That's insane," Jim Cramer said Wednesday.

Follow Nvidia’s Q2 2027 earnings for data center results, guidance, AI demand and NVDA stock reaction in real time.

Analysts expect the company to launch new iPhones and Apple Watches at the event, including the company's first folding phone

These are some of the stocks posting the largest moves in midday trading.

Meta and state attorneys general settled a federal trial centering on allegations that company misrepresented the extent of child-related mental health harms.

OpenAI’s Jalapeño chip beat Nvidia Blackwell systems on key inference-efficiency tests as custom AI silicon gains ground among major tech companies.

Here are five key things investors need to know to start the trading day.

The South Korean automaker wants to keep going by ramping up production at a new $7.6 billion plant in Georgia to capture more sales and market share.

These are the stocks posting the largest moves premarket.

Short dramas' model posits a new alternative to traditional entertainment models, but distribution poses rising cost and audience retention challenges.

It's a sign of adoption of Huawei technology outside China, despite the U.S. restricting the company from working with American suppliers such as Google.

Mechanical Turk launched in 2005 as a way to farm out tasks that are easy for humans to complete but too challenging for computers.

HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.

These are the stocks posting the largest moves midday.

The U.S. can pressure Chinese banks over Iran through access to its financial system, while Beijing is building alternatives such as CIPS.

These are the stocks posting the largest moves in early trading.

Bugatti CEO Mate Rimac told CNBC he thinks high-end sports cars will continue to have combustion engines "for a very long time" even with the rise of EVs.

Indian IT services giant TCS has secured a $1.5 billion contract to deploy AI for German sports carmaker Porsche.

Speculators still see yields hitting new highs in 2026 and ending the year at levels elevated from where they're currently trading.

Goldman Sachs is embracing AI, but one of its senior tech leaders warns that it comes with an unintended risk: weakening the reasoning skills of future bankers.

Bitcoin and crypto stocks extended their rally after the flagship cryptocurrency broke out of its trading range.

President Donald Trump said the U.S. will raise tariffs on imports of cars, trucks and auto parts from Canada to 50% on Jan. 1, 2027

These are the stocks posting the largest moves premarket.

Alibaba shares plunged 10% after the tech giant priced a $10.2 billion share placement to fund its growing AI investments.

Citigroup and Wells Fargo have room to buy a big regional bank as regulators have opened the door to megadeals. Five regional banks make sense as targets.

Speculators on the prediction market platform think it's most likely that the cryptocurrency will end 2026 close to where it's now trading.

The bigger issue at hand may be that many Americans fall into a large, uncertain middle ground – neither firmly pro-vaccine nor staunchly opposed.

BioMarin will acquire Alesta Therapeutics for $275 million upfront, bolstering BioMarin's unit focused on rare skeletal conditions.

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI.

Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.

A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.

Novo Nordisk CEO defended the company's decision to sue rival Eli Lilly over its weight-loss drug advertising.

Federal dollars in the two health insurance programs would not go toward gender-affirming care, but states could still cover the treatments.

The quarter wasn't totally clean, but strong profitability matters the most.

Doctors and other experts say that splitting the measles, mumps and rubella shot has no scientific basis and is unlikely to get off the ground.

Jazz Pharmaceuticals will acquire Actio Biosciences, Inc., a deal that expands Jazz's pipeline and presence in rare epilepsy treatments.

Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.

The order builds on the Trump administration's efforts to reshape the childhood shot schedule under HHS Secretary RFK Jr., a longtime a vaccine skeptic.

Genetic testing is helping doctors identify rare diseases earlier, opening the door to treatment options before symptoms appear.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

"The cancer has spread, is metastasized into his bones and further. It's very painful. It's very debilitating in many respects," Hunter Biden said.

Traffic to salad chains has fallen as consumers avoid greens due to the ongoing cyclospora outbreaks across the U.S.

"On the advice of my doctors, I'll maintain an intensive regimen of physical therapy from home during the state work period," the 84-year-old McConnell said.

CAMP4 is preparing a Phase 1/2 trial of an experimental SYNGAP1 therapy, marking a major milestone for patients with the rare disease.